The mRNA COVID vaccine used this past season showed no elevated risk of any of the 29 serious adverse events assessed.

RNA has emerged as a powerful tool across vaccines, protein replacement therapies and gene editing. Central to these innovations is the need for ultra-fast, high-quality in vitro transcription (IVT) ...

Mary Talley Bowden, MD, founder of Americans for Health Freedom, an advocacy group that has lobbied against mRNA shots, ...

On July 30, DXVX announced that it has entered into a co-development and license agreement valued at approximately USD 220 million with a U.S.-based biotech company for its mRNA-based cancer vaccine.

Researchers at Harvard Medical School and Brigham and Women's Hospital designed an ingestible capsule that delivers liquid mRNA to the intestines, producing gene expression and reducing inflammation ...

What if mRNA vaccines could be made more powerful and less irritating? Scientists at the University of Pennsylvania have ...

The upcoming report from Moderna (MRNA) is expected to reveal quarterly loss of -$2.99 per share, indicating an increase of 10.2% compared to the year-ago period. Analysts forecast revenues of $127.17 ...

Researchers at the University of Florida have developed a new mRNA-based vaccine that, when combined with checkpoint ...

A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...

The experimental mRNA vaccine developed at the University of Florida has shown the ability to supercharge the immune system ...

A KAIST research team led by Professor Won Do Heo (Department of Biological Sciences) has developed an optogenetic platform, ...

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...